News

AddToAny

Google+ Facebook Twitter Twitter

New delivery method for immunotherapy combination

Using nanoparticles to bind molecules that can unleash and stimulate immune cells, US researchers found they could more effectively trigger the body’s defence systems against cancer in laboratory studies.

The researchers believe that their findings offer a promising new nanotechnology-based delivery method for an immunotherapy combination. Andrew Z Wang, Associate Professor at the University of North Carolina (UNC) School of Medicine, was one of the research team.

He said: “Our study suggests that if you’re able to present two different therapeutics at the same time to immune cells to help them fight cancer, the effect is greater.

“It’s difficult to deliver them at the same time unless you 
tie them together, and a nanoparticle is one great way to tie the two together.”

T-cells can fight and kill tumours, but they have regulatory signals that limit their effectiveness.

Treatments called checkpoint inhibitors have been developed to “release the brakes” on immune cells, and have been shown to be a powerful tool to fight lung cancer and melanoma for a subset of patients. Clinical trials have been launched to test combining checkpoint inhibitors that release the immune system’s brakes with treatments designed to send “green light” signals to boost the immune response.

UNC researchers developed a mechanism that combines these two compound types on a single nanoparticle with the goal of producing better results. Their research has been published in the journal Advanced Materials.

bit.ly/BS_JuneNews02

Related Articles

The new dawn of immunotherapy

Steven Rosenberg made headlines around the globe for a breakthrough that could make immunotherapy a frontline cancer treatment.

Vaccine to treat lung cancer

A first-of-its-kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer.

Journal-based learning: iStock

July: Journal-based learning

Each article’s contents should be read, researched and understood, and you should then come to a decision on each question. The pass mark is 17 out of 20 questions answered correctly. JBL exercises may be completed at any time until the published deadline date. Please select your choice of correct answers and complete the exercises online at: www.ibms.org/cpd/jbl

Could bacteriophages replace antibiotics?

A small-scale preliminary trial concludes that bacteriophages could be a viable replacement for antibiotics in the future.

Top